Circulating TRAIL shows a significant post-partum decline associated to stressful conditions

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Zauli, Giorgio ^a   Monasta, Lorenzo ^a   Rimondi, Erika ^b   Brumatti, Liza ^a   Radillo, Oriano ^a   Ronfani, Luca ^a   Montico, Marcella ^a   D'Ottavio, Giuseppina ^a   Alberico, Salvatore ^a   Secchiero, Paola ^b  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HYDROCORTISONE; INSULIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; BIOLOGICAL MARKER; TNFSF10 PROTEIN, HUMAN;

ADULT; ARTICLE; BIOCHEMICAL COMPOSITION; BODY MASS; CONTROLLED STUDY; FEMALE; FETUS DISTRESS; GESTATION PERIOD; GLUCOSE BLOOD LEVEL; HUMAN; LABOR INDUCTION; MATERNAL AGE; MATERNAL STRESS; NULLIPARA; OBSTETRIC ANALGESIA; PROTEIN BLOOD LEVEL; PUERPERIUM; UMBILICAL CORD BLOOD; VAGINAL DELIVERY; BLOOD; FETUS BLOOD; LABOR; METABOLISM; MULTIVARIATE ANALYSIS; NONPARAMETRIC TEST; PHYSIOLOGICAL STRESS; PHYSIOLOGY; PREGNANCY; PREGNANCY OUTCOME; STATISTICAL MODEL;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; FETAL BLOOD; FETAL DISTRESS; HUMANS; LABOR, OBSTETRIC; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY OUTCOME; STATISTICS, NONPARAMETRIC; STRESS, PHYSIOLOGICAL; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 83355170743     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027011     Document Type: Article

References (38)

1. Secchiero P, Zauli G, (2008) TNF-related apoptosis-inducing ligand and the regulation of hematopoiesis. Curr Op Hematol 15: 42-48.
2. Ashkenazi A, (2008) Targeting the extrinsic apoptosis pathway in cancer. Cytokine Growth Factor Rev 19: 325-331.
3. Di Pietro R, Zauli G, (2004) Emerging non-apoptotic functions of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L. J Cell Physiol 201: 331-340.
4. Kawano N, Mori K, Emoto M, Lee E, Kobayashi I, et al. (2011) Association of serum TRAIL levels with atherosclerosis in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 91: 316-320.
5. Shaker OG, El-Shehaby A, Nabih M, (2010) Possible role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as markers of plaque instability in coronary artery disease. Angiology 61: 756-762.
6. Secchiero P, Corallini F, Ceconi C, Parrinello G, Volpato S, et al. (2009) Potential prognostic significance of decreased serum levels of TRAIL after acute myocardial infarction. PLoS One 4: e4442.
7. Niessner A, Hohensinner PJ, Rychli K, Neuhold S, Zorn G, et al. (2009) Prognostic value of apoptosis markers in advanced heart failure patients. Eur Heart J 30: 789-796.
8. Mori K, Ikari Y, Jono S, Shioi A, Ishimura E, et al. (2010) Association of serum TRAIL level with coronary artery disease. Thromb Res 125: 322-325.
9. Secchiero P, Gonelli A, Corallini F, Ceconi C, Ferrari R, et al. (2010) Metalloproteinase 2 cleaves in vitro recombinant TRAIL: potential implications for the decreased serum levels of TRAIL after acute myocardial infarction. Atherosclerosis 211: 333-336.
10. Liabeuf S, Barreto DV, Barreto FC, Chasseraud M, Brazier M, et al. (2010) The circulating soluble TRAIL is a negative marker for inflammation inversely associated with the mortality risk in chronic kidney disease patients. Nephrol Dial Transplant 25: 2596-2602.
11. Chen L, Liu X, Zhu Y, Cao Y, Sun L, et al. (2004) Localization and variation of TRAIL and its receptors in human placenta during gestation. Life Sci 74: 1479-1486.
12. Phillips TA, Ni J, Pan G, Ruben SM, Wei YF, et al. (1999) TRAIL (Apo-2L) and TRAIL receptors in human placentas: implications for immune privilege. J Immunol 162: 6053-6059.
13. Phillips TA, Ni J, Hunt JS, (2001) Death-inducing tumour necrosis factor (TNF) superfamily ligands and receptors are transcribed in human placentae, cytotrophoblasts, placental macrophages and placental cell lines. Placenta 22: 663-672.
14. Keogh RJ, Harris LK, Freeman A, Baker PN, Aplin JD, et al. (2007) Fetal-derived trophoblast use the apoptotic cytokine tumor necrosis factor-alpha-related apoptosis-inducing ligand to induce smooth muscle cell death. Circ Res 100: 834-841.
15. Secchiero P, Corallini F, di Iasio MG, Gonelli A, Barbarotto E, et al. (2005) TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release. Blood 105: 3413-3419.
16. Alladina SJ, Song JH, Davidge ST, Hao C, Easton AS, (2005) TRAIL-induced apoptosis in human vascular endothelium is regulated by phosphatidylinositol 3-kinase/Akt through the short form of cellular FLIP and Bcl-2. J Vasc Res 42: 337-347.
17. Secchiero P, Candido R, Corallini F, Zacchigna S, Toffoli B, et al. (2006) Systemic TRAIL delivery shows anti-atherosclerotic activity in apoE-null diabetic mice. Circulation 114: 1522-1530.
18. Nomura S, Ishii K, Inami N, Uoshima N, Ishida H, et al. (2007) Role of soluble tumor necrosis factor-related apoptosis-inducing ligand concentrations after stem cell transplantation. Transpl Immunol 18: 115-121.
19. Zauli G, Corallini F, Bossi F, Fischietti F, Durigotto P, et al. (2007) Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo. Blood 110: 536-543.
20. Naylor KE, Rogers A, Fraser RB, Hall V, Eastell R, et al. (2003) Serum osteoprotegerin as a determinant of bone metabolism in a longitudinal study of human pregnancy and lactation. J Clin Endocrinol Metab 88: 5361-5365.
21. Volpato S, Ferrucci L, Secchiero P, Corallini F, Zuliani G, et al. (2011) Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults. Atherosclerosis 215: 452-455.
22. Liabeuf S, Barreto DV, Barreto FC, Chasseraud M, Brazier M, et al. (2010) The circulating soluble TRAIL is a negative marker for inflammation inversely associated with the mortality risk in chronic kidney disease patients. Nephrol Dial Transplant 25: 2596-2602.
23. von Versen-Hoeynck FM, Hubel CA, Gallaher MJ, Gammill HS, Powers RW, (2009) Plasma levels of inflammatory markers neopterin, sialic acid, and C-reactive protein in pregnancy and preeclampsia. Am J Hypertens 22: 687-692.
24. Liguori A, D'Armiento FP, Palagiano A, Palinski W, Napoli C, (2008) Maternal C-reactive protein and developmental programming of atherosclerosis. Am J Obstet Gynecol 198: 281.e1-5.
25. Swellam M, Samy N, Wahab SA, Ibrahim MS, (2009) Emerging role of endothelial and inflammatory markers in preeclampsia. Dis Markers 26: 127-133.
26. Lonergan M, Aponso D, Marvin KW, Helliwell RJ, Sato TA, et al. (2003) Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptors, and the soluble receptor osteoprotegerin in human gestational membranes and amniotic fluid during pregnancy and labor at term and preterm. J Clin Endocrinol Metab 88: 3835-3844.
27. Klugman SD, Gross SJ, Liang J, Livne K, Gross B, et al. (2008) Expression of keratin 8 and TNF-related apoptosis-inducing ligand (TRAIL) in Down syndrome placentas. Placenta 29: 382-384.
28. Bai X, Williams JL, Greenwood SL, Baker PN, Aplin JD, et al. (2009) A placental protective role for trophoblast-derived TNF-related apoptosis-inducing ligand (TRAIL). Placenta 30: 855-860.
29. Sokolov DI, Kolobov AV, Lesnichija MV, Kostiouchek IN, Stepanova OI, et al. (2009) Regulatory mechanisms for apoptosis in placental tissue during normal pregnancy and gestosis-complicated pregnancy. Bull Exp Biol Med 148: 766-770.
30. Groebner AE, Schulke K, Unterseer S, Reichenbach HD, Reichenbach M, et al. (2010) Enhanced proapoptotic gene expression of XAF1, CASP8 and TNFSF10 in the bovine endometrium during early pregnancy is not correlated with augmented apoptosis. Placenta 31: 168-177.
31. Fluhr H, Sauter G, Steinmüller F, Licht P, Zygmunt M, (2009) Nonapoptotic effects of tumor necrosis factor-related apoptosis-inducing ligand on interleukin-6, leukemia inhibitory factor, interleukin-8, and monocyte chemoattractant protein 1 vary between undifferentiated and decidualized human endometrial stromal cells. Fertil Steril 92: 1420-1423.
32. Jung C, Ho JT, Torpy DJ, Rogers A, Doogue M, et al. (2011) A longitudinal study of plasma and urinary cortisol in pregnancy and postpartum. J Clin Endocrinol Metab 96: 1533-1540.
33. Camozzi V, Sanguin F, Albigier N, Scaroni C, Mantero F, et al. (2010) Persistent increase of osteoprotegerin levels after cortisol normalization in patients with Cushing's syndrome. Eur J Endocrinol 162: 85-90.
34. Hofbauer LC, Schoppet M, Christ M, Teichmann J, Lange U, (2006) Tumour necrosis factor-related apoptosis-inducing ligand and osteoprotegerin serum levels in psoriatic arthritis. Rheumatology (Oxford) 45: 1218-1222.
35. Zai-Xing Y, Yan L, Hao W, Ye Z, Chang L, et al. (2008) Preliminary clinical measurement of the expression of TNF-related apoptosis inducing ligand in patients with ankylosing spondylitis. J Clin Lab Anal 22: 138-145.
36. Michowitz Y, Goldstein E, Roth A, Afek A, Abashidze A, et al. (2005) The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis. J Am Coll Cardiol 45: 1018-1024.
37. Watt V, Chamberlain J, Steiner T, Francis S, Crossman D, (2011) TRAIL attenuates the development of atherosclerosis in apolipoprotein E deficient mice. Atherosclerosis 215: 348-354.
38. Kawano N, Mori K, Emoto M, Lee E, Kobayashi I, et al. (2011) Association of serum TRAIL levels with atherosclerosis in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 91: 316-312.